b'SensorThe worlds smallest *115-day sensor.FreeStyle Libre 3 Plus: Easy to apply andEasy for you to partner The smallest, most comfortable to with your patients foraccurate iCGM sensor forwear 3for up to more productivetreatment decisions1,2 15 days discussions 4Contact your government team at 1-844-324-5807 or visit Provider.Freestyle.AbbottMedicare and other payor criteria may apply. The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView. * Among patient-applied sensors.Based on patient applied FDA cleared iCGMs replacing blood glucose testing for diabetes treatment decisions.Based on the same glucose algorithm between FreeStyle Libre 2 and FreeStyle Libre 3 family of sensors.Multicenter study evaluating sensor data from FreeStyle Libre 3 and Dexcom G7 compared to blood plasma glucose under real world conditions. Study limitations: Study subjects followed their daily routines and were not exposed to risks of hyperglycemia or hypoglycemia manipulations, neither sensor was evaluated for accuracy during times of rapidly changing glucose. Outcome measures: Differences in mean absolute relative difference, number and percentage of matched glucose pairs within 20 mg/dL/20% of reference values. Results from 55 subjects (minimum required sample size: 42). Registration in clinicaltrials.gov is not required as the study does not meet the definition of Applicable Clinical Trial. Study funding provided by Abbott. ^ Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 3 has the same features as FreeStyle Libre 14 day system with real-time glucose alarms. Therefore the study data is applicable to both products.1. Data on file. Abbott Diabetes Care.2. Hanson, K. Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems. J Diabetes Sci Technol 18, no. 3(2024): 598-607. https://doi.org/10.1177/19322968231225676 3. Alva S, et al. Diabetes Ther. (2023): https://doi.org/10.1007/s13300-023-01385-6. 4. Unger, J. Postgrad Med (2020):https://doi.org/10.1080/00325481.2020.1744393.Important Safety InformationFailure to use FreeStyle Libre 3 system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or https://www.freestyle.abbott/us-en/safety-information.html for safety info.The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. 2024 Abbott. ADC-34125 v7.0'